Press Releases Qiagen N.V. Swiss Exchange

Equities

QGEN

NL0015001WM6

Market Closed - Swiss Exchange Other stock markets 09:05:20 28/06/2019 pm IST			5-day change	1st Jan Change
39.45 ^CHF	+0.84%		-.--%	-.--%

31/05	Qiagen, Myriad Genetics Team Up to Develop Homologous Recombination Deficiency Test	MT
31/05	Qiagen, Myriad Genetics Partner to Create Easily Distributable Cancer Tumor Test	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications	31/05	AQ
QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine	30/05	AQ
QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support	15/05	AQ
Qiagen N : 2023 Annual Report 2023 Sustainability Statement	13/05	PU
QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results	13/05	AQ
Qiagen N : 2024 QIAGEN N.V. Annual General Meeting of Shareholders Presentation	08/05	PU
Qiagen N : 2023 Annual Report 2023 Annual Financial Report	08/05	PU
Qiagen N : Annual Report 2023, including the Reports of the Managing Board and the Supervisory Board of N.V.	08/05	PU
QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics	08/05	AQ
Qiagen N : Remuneration Report 2023	07/05	PU
Qiagen N : Q1 2024 Results Investor Introduction	03/05	PU
Qiagen N : Virtual Berenberg MDx Day Investor Introduction	03/05	PU
QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications	03/05	AQ
Qiagen N : First Quarter 2024 SEC Filing	02/05	PU
Q1 2024 Results Conference Call Presentation: April 30, 2023	30/04	PU
Qiagen N : QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance	30/04	PU
Q1 2024 Results Press Release: April 29, 2024, 22:05 CET	30/04	PU
Qiagen: Q1 Earnings Snapshot	30/04	AQ
QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance	30/04	AQ
Qiagen N : 2023 Annual Report 2023 IFRS Annual Report	25/04	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

QIAGEN : A decent start to 2024; guidance unchanged

April 30, 2024 at 07:02 pm IST